100% Natural Multifunctional Mood Balancer

Saffrox™ is a new 100% natural advanced Mood Balancer  composed of Saffron, turmeric, magnesium and vitamins.

Everyone experiences an occasional blue mood or depression.
approximately 60–80% of these users do not obtain full symptom remission(4). Pharmacological interventions are also associated with several adverse effects that contribute to their early discontinuation(5). Nausea, diarrhea, headache, low sex drive and difficulty achieving orgasm during sex fact turns the use of antidepressants to disadvantage.

Saffrox™ is The Smart Solution for Mood Balancer.


The one a day dosage makes Saffrox™, user friendly with high compliance and customer satisfaction.

Saffrox advantages:

  • Higher content in bioactive compounds.
  • Higher stability because of its natural antioxidant content and its scavenging properties.
  • Bioavailable.
  • No side effects.
  • Safe and well tolerated ingredient.
  • Act in synergy against oxidative stress produced during low mood states.

EFSA claim on Folate: Contributes to normal psychological function.

1. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine : a double-blind, randomized pilot trial. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. J Ethnopharmacol. 2005 Feb 28;97(2):281-4.
2. Saffron :randomized double-blind placebo-controlled study, L.Kashani,F.Raisi,S.Saroukhanietal.”HumanPsychopharmacology,vol.28,no.1,pp.54–60,2013.
3. Comparison of Crocus sativus L. and imipramine : a pilot double-blind randomized trial S. Akhondzadeh, H. Fallah-Pour, K. Afkham, A.-H. Jamshidi, and F. Khalighi-Cigaroudi, “BMC Complementary and Alternative Medicine,vol.4,article12,2004.
4. The epidemiology of depression across cultures. Ronald C. Kessler and Evelyn J. Bromet, Annu Rev Public Health. 2013; 34: 119–138.
5. Selective serotonin reuptake inhibitor discontinuation – Side effects and other factors that influence medication adherence. Goethe JW, Woolley SB, Cardoni AA, et al. Journal of Clinical Psychopharmacology. 2007;27:451–458.
6.  review. Sinyor M1, Schaffer A, Levitt A. Can J Psychiatry. 2010 mar;55(3):126-35.
7. The role of L-methylfolate in depressive disorders Farah A, CNS Spectr. 2009 Jan;14(1 Suppl 2):2.